Zevra Therapeutics (ZVRA) Assets Growth (5y) (2019 - 2026)
Zevra Therapeutics (ZVRA) Assets Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,899.87 Bn | 1,899.81 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 470.43 Bn | 465.64 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.20 Bn | 61.44 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.75 Bn | 61.75 Bn | - |
| 8 | Argenx Se | 56.15 Bn | 50.96 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | Zevra Therapeutics | 567.71 Mn | 367.09 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.23% |
| Dec 31, 2025 | 90.97% |
| Sep 30, 2025 | 88.99% |
| Jun 30, 2025 | 83.47% |
| Mar 31, 2025 | 81.02% |
| Dec 31, 2024 | 76.14% |
| Sep 30, 2024 | 71.56% |
| Jun 30, 2024 | 61.83% |
| Mar 31, 2024 | 50.08% |
| Dec 31, 2023 | 45.15% |
| Sep 30, 2023 | 49.30% |
| Jun 30, 2023 | 25.42% |
| Dec 31, 2022 | 17.07% |
| Sep 30, 2022 | 14.97% |
| Jun 30, 2022 | 12.47% |
| Mar 31, 2022 | -14.93% |
| Dec 31, 2021 | 9.39% |
| Sep 30, 2021 | 7.73% |
| Jun 30, 2021 | 5.81% |
| Mar 31, 2021 | -4.18% |